SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CA3CAB890C0E1BCE961F1088C4952B291A574E4CA919B0E4C68B918F4350CBB880D3359961D44189E9A6CB9C53CE26BB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CA3CAB890C0E1BCE961F1088C4952B291A574E4CA919B0E4C68B918F4350CBB880D3359961D44189E9A6CB9C53CE26BB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CA3CAB890C0E1BCE961F1088C4952B291A574E4CA919B0E4C68B918F4350CBB880D3359961D44189E9A6CB9C53CE26BB
http://www.w3.org/2000/01/rdf-schema#comment
"Study revealed no association between the 15 tagSNPs of CACNA1A 1C and 1H and antiepileptic drug efficacy in the Chinese Han epileptic population; the TAGAA haplotype of CACNA1A may be a risk factor for drug resistance"
xsd:string
http://purl.uniprot.org/uniprot/#_FA19487360119C42EF5546E0C38CAEE2B8E9AD4819CB0F1CC59DEFF186FBBB9E95EBFC41714ADE081199E1CD0CF45710
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CA3CAB890C0E1BCE961F1088C4952B291A574E4CA919B0E4C68B918F4350CBB880D3359961D44189E9A6CB9C53CE26BB
http://purl.uniprot.org/uniprot/Q9NS89
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CA3CAB890C0E1BCE961F1088C4952B291A574E4CA919B0E4C68B918F4350CBB880D3359961D44189E9A6CB9C53CE26BB
http://purl.uniprot.org/uniprot/#_Q9NS89-mappedCitation-26216687
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CA3CAB890C0E1BCE961F1088C4952B291A574E4CA919B0E4C68B918F4350CBB880D3359961D44189E9A6CB9C53CE26BB